Sleep disturbance, norepinephrine, and D-dimer are all related in elderly caregivers of people with Alzheimer disease

Sleep

Volumn 29, Issue 10, 2006, Pages 1347-1352

  Mausbach, Brent T ^a,e   Ancoli Israel, Sonia ^a,b   Von Känel, Roland ^a,c   Patterson, Thomas L ^a   Aschbacher, Kirstin ^a   Mills, Paul J ^a   Ziegler, Michael G ^d   Dimsdale, Joel E ^a   Calleran, Susan ^a   Grant, Igor ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer disease; Cardiovascular disease; Caregiving; Catecholamines; Coagulation; SAM arousal; Sleep

Indexed keywords

ADRENALIN; BIOLOGICAL MARKER; D DIMER; NORADRENALIN;

ADRENAL MEDULLA; ADRENALIN BLOOD LEVEL; ADULT; AGE; AGED; ALZHEIMER DISEASE; AROUSAL; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CAREGIVER; CLINICAL ARTICLE; FEMALE; GENDER; HEMOSTASIS; HUMAN; MALE; MORBIDITY; MORTALITY; MULTIPLE REGRESSION; NORADRENALIN BLOOD LEVEL; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP DISORDER; SLEEP WAKING CYCLE;

EID: 33750019164     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/29.10.1347     Document Type: Article

References (49)

1. Schulz R, O'Brien AT, Bookwala J, Fleissner K. Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes. Gerontologist 1995.:35:771-91.
2. Brodaty H, Hadzi-Pavlovic D. Psychosocial effects on carers of living with persons with dementia. Aust N Z J Psychiatry 1990:24:351-61.
3. Grant I. Caregiving may be hazardous to your health. Psychosom Med 1999:61:420-3.
4. Mausbach BT, Dimsdale JE, Ziegler MG, et al. Depressive symptoms predict norepinephrine response to a psychological stressor task in Alzheimer's caregivers. Psychosom Med 2005:67:638-42.
5. Schulz R, Beach SR. Caregiving as a risk factor for mortality: the Caregiver Health Effects Study. JAMA 1999:282:2215-9.
6. Ory MG, Hoffman RR, 3rd, Yee JL, Tennstedt S, Schulz R. Prevalence and impact of caregiving: a detailed comparison between dementia and nondementia caregivers. Gerontologist 1999:39:177-85.
7. Shaw WS, Patterson TL, Ziegler MG, Dimsdale JE, Semple SJ, Grant I. Accelerated risk of hypertensive blood pressure recordings among Alzheimer caregivers. J Psychosom Res 1999:46:215-27.
8. Lee S, Colditz GA, Berkman LF, Kawachi I. Caregiving and risk of coronary heart disease in U.S. women: a prospective study. Am J Prev Med 2003:24:113-9.
9. McKibbin CL, Ancoli-Israel S, Dimsdale J, et al. Sleep in spousal caregivers of people with Alzheimer disease. Sleep 2005:28:1245-50.
10. Schwartz S, McDowell Anderson W, et al. Insomnia and heart disease: a review of epidemiologic studies. J Psychosom Res 1999:47:313-33.
11. Wilcox S, King AC. Sleep complaints in older women who are family caregivers. J Gerontol B Psychol Sci Soc Sci 1999:54:P189-98.
12. Happe S, Berger K. The association between caregiver burden and sleep disturbances in partners of patients with Parkinson's disease. Age Ageing 2002:31:349-54.
13. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000:283:1829-36.
14. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003:290:1906-14.
15. Parish JM, Shepard JW, Jr. Cardiovascular effects of sleep disorders. Chest 1990:97:1220-6.
16. von Känel R, Dimsdale JE. Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 2003:124:1956-67.
17. Mills PJ, Dimsdale JE. Sleep apnea: a model for studying cytokines, sleep, and sleep disruption. Brain Behav Immun 2004:18:298-303.
18. Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 2004:79:1036-46.
19. Ziegler MG, Mills PJ, Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 2001:120:887-93.
20. Loredo JS, Ziegler MG, Ancoli-Israel S, Clausen JL, Dimsdale JE. Relationship of arousals from sleep to sympathetic nervous system activity and BP in obstructive sleep apnea. Chest 1999:116:655-9.
21. Ziegler MG, Nelesen R, Mills P, Ancoli-Israel S, Kennedy B, Dimsdale JE. Sleep apnea, norepinephrine-release rate, and daytime hypertension. Sleep 1997:20:224-31.
22. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001:163:19-25.
23. Nieto FJ, Herrington DM, Redline S, Benjamin EJ, Robbins JA. Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 2004:169:354-60.
24. Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005:172:613-8.
25. von Känel R, Dimsdale JE, Ancoli-Israel S, et al. Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin d-dimer in older caregivers of people with Alzheimer's disease. J Am Geriatr Soc 2006:54:431-7.
26. von Känel R, Dimsdale JE. Fibrin D-dimer: a marker of psychosocial distress and its implications for research in stress-related coronary artery disease. Clin Cardiol 2003:26:164-8.
27. Lip GY, Lowe GD. Fibrin D-dimer: a useful clinical marker of thrombogenesis? Clin Sci 1995:89:205-14.
28. Cornuz JGW, Hayoz D, Staoianov R, Depairon M, Yersin B. Clinical prediction of deep venous thrombosis using two risk assessment methods in combination with rapid quantitative d-dimer testing. Am J Med 2002:112:198-203.
29. de Moerloose P, Desmarais S, Bounameaux H, et al. Contribution of a new, rapid, individual and quantitative automated D-dimer ELISA to exclude pulmonary embolism. Thromb Haemost 1996:75:11-3.
30. Eichinger S, Minar E, Bialonczyk C, et al. D-dimer levels and risk of recurrent venous thromboembolism. JAMA 2003:290:1071-4.
31. von Känel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000:65:357-69.
32. Vosburgh CH, Richards AN. An experimental study of the sugar content and extra vascular coagulation of the blood after administration of adrenalin. Am J Physiol 1903:9:35-51.
33. Cannon WB, Gray H. Factors affecting the coagulation time of blood. II. The hastening or retarding of coagulation by adrenalin injections. Am J Physiol 1914:34:232-42.
34. von Känel R, Mills PJ, Ziegler MG, Dimsdale JE. Effect of beta2-adrenergic receptor functioning and increased norepinephrine on the hypercoagulable state with mental stress. Am Heart J 2002:144:68-72.
35. Ikarugi H, Taka T, Nakajima S, et al. Norepinephrine, but not epinephrine, enhances platelet reactivity and coagulation after exercise in humans. J Appl Physiol 1999:86:133-8.
36. von Kanel R, Dimsdale JE, Ancoli-Israel S, et al. Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer's disease. J Am Geriatr Soc 2006;54:431-7
37. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983:13:595-605.
38. Stukenberg KW, Dura JR, Kiecolt-Glaser JK. Depression screening scale validation in an elderly, community-dwelling population. Psychol Assess 1990:2:134-8.
39. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986:51:1173-82.
40. MacKinnon DP, Dwyer JH. Estimating mediated effects in prevention studies. 1993:17:144-58.
41. Danesh J, Whincup P, Walker M, et al. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation 2001:103:2323-7.
42. Samel A, Vejvoda M, Maass H. Sleep deficit and stress hormones in helicopter pilots on 7-day duty for emergency medical services. Aviat Space Environ Med 2004:75:935-40.
43. Irwin MR, Ziegler M. Sleep deprivation potentiates activation of cardiovascular and catecholamine responses in abstinent alcoholics. Hypertension 2005:45:252-7.
44. Irwin M, Thompson J, Miller C, Gillin JC, Ziegler M. Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. J Clin Endocrinol Metabol 1999:84:1979-85.
45. Jern C, Eriksson E, Tengborn L, Risberg B, Wadenvik H, Jern S. Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost 1989:62:767-71.
46. Robertson D, Johnson GA, Robertson RM, Nies AS, Shand DG, Dates JA. Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation 1979:59:637-43.
47. Farrell PA, Gustafson AB, Morgan WP, Pert CB. Enkephalins, catecholamines, and psychological mood alterations: effects of prolonged exercise. Med Sci Sports Exerc 1987:19:347-53.
48. Kotchen TA, Hartley LH, Rice TW, Mougey EH, Jones LG, Mason JW. Renin, norepinephrine, and epinephrine responses to graded exercise. J Appl Physiol 1971:31:178-84.
49. McCurry SM, Logsdon RG, Vitiello MV, Teri L. Successful behavioral treatment for reported sleep problems in elderly caregivers of dementia patients: a controlled study. J Gerontol B Psychol Sci Soc Sci 1998:53:P122-9.